Description
The National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) will be participating in the 2021 American Heart Association (AHA) Virtual Scientific Sessions from November 13 – 15, 2021. NHLBI research and NHLBI-funded research will be presented at more than 30 sessions. See the schedule below for a snapshot of NHLBI’s sessions at AHA 2021.Visit AHA’s website and program planner for a full schedule and updates.
Please note: schedule is subject to change.
Saturday, November 13, 2021
Live Sessions
Session CH.AOS.463
226 - Impact of Norwood shunt type on cardiac function and clinical outcomes in survivors to early adolescence with hypoplastic left heart syndrome and other single right ventricular anomalies: A report from the single ventricle reconstruction (SVR) III study
Caren Goldberg, M.D.
8:12 – 8:24 a.m. ET
LATE-BREAKING Session LBS.01
226 Evaluating the benefit of concomitant tricuspid repair during mitral valve surgery
Annetine C. Gelijns, Ph.D., Marissa Miller, D.V.M., Wendy Taddei-Peters, Ph.D., Neal Jeffries, Ph.D.
9:43 – 9:53 a.m. ET
LATE-BREAKING Session LBS.01
Efficacy and safety of an external support device for saphenous vein coronary bypass grafts: The VEST trial
10:11 – 10:19 a.m. ET
Session CS.ME.1188
Cardiovascular health after 10 years: What have we learned and what is the future?
Moderator: David Goff, M.D., Ph.D.
11:00 a.m. – 12:15 p.m. ET
Session LS.08
National Heart, Lung, and Blood Institute Small Business Grant Program: Live Virtual Pitch Event
Recovery Force, Optima Integrated Health, Cornovus Pharmaceuticals, Elucid Bio, Exhalix, 3DT Holdings
3:00 – 4:30 p.m. ET
Session FS.02
Whole-heart quantification and characterization of coronary atherosclerotic burden and risk of major adverse cardiovascular events: The Ischemia Trial
James Min, M.D.
4:58 – 5:06 p.m. ET
On-Demand Sessions
Session QU.RFO.16
Neighborhood perception is associated with physical activity and nutrition self-efficacy among African Americans: The Washington, DC cardiovascular health and needs Assessment
Foster Oseh Baah, Ph.D., Tiffany Powell-Wiley, M.D.
8:00 a.m. – 5:30 p.m. ET
Session PH.AOS.399
V180 - Plasma cell-free DNA predicts survival and maps tissue-specific sources of injury in pulmonary arterial hypertension
Michael Solomon, M.D., Mehdi Pirooznia, M.D., Ph.D., Sean Agbor-Enoh M.D., Ph.D., Manreet Kanwar, M.D.
8:00 a.m. – 5:30 p.m. ET
Session AT.AOS.378
280 - Regulation of blood pressure by smooth muscle TRPV4 channels under normal and hypertensive conditions
Yen-Lin Chen, Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session EP.CVS.389
NHLBI’s vision for preserving cardiovascular health across the life course
David Goff, M.D., Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session EP.AOS.424
Pursuing a heart-healthy planet
David Goff, M.D., Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session LF.EC.55
Meet the experts: Leaders of NHLBI and NINDS-funded cohorts
NHLBI: ARIC, CARDIA, CHS, FHS, HCHS/SOL,JHS, nuMoM2b, RURAL; NCI: HPFS; NINDS/NIA: REGARDS
8:00 a.m. – 5:30 p.m. ET
Session AT.CVS.245
Single-cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm
Bo Liu, Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session CM.RFO.22
RF66 - Multidimensional sleep health is associated with cardiometabolic health in a nationally representative sample of US adults
Nour Makarem, Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session HF.CVS.279
How funding sponsors are supporting new methods of achieving equity
George Mensah, M.D.
8:00 a.m. – 5:30 p.m. ET
Session IM.CVS.392
Whither disparities in hypertrophy/heart failure
George Mensah, M.D.
8:00 a.m. – 5:30 p.m. ET
Session LF.CVS.250
Role of the community in cardiometabolic care - impact of infrastructure and communities on health
Tiffany Powell-Wiley, M.D.
8:00 a.m. – 5:30 p.m. ET
Session EA.AOS.456
195 - Race-specific models to predict in-hospital mortality in patients with heart failure using machine learning: The American Heart Association get with the guidelines registry
Tiffany Powell-Wiley, M.D., David Kao, M.D.
8:00 a.m. – 5:30 p.m. ET
Session EP.RFO.15
RF41 - Racial and gender differences in lifetime healthcare costs across cardiovascular risk factors
Tiffany Powell-Wiley, M.D., Rohan Khera, M.D.
8:00 a.m. – 5:30 p.m. ET
Session GE.APS.1221: P1391
Epigenetic risk score capturing alcohol consumption is not associated with cardiac structure and function: The Framingham Heart Study
Helena Bui, Amena Keshawarz, Ph.D., Vasan Ramachandran, M.D., Daniel Levy, M.D.
8:00 a.m. – 5:30 p.m. ET
Session PH.CVS.329
Putting PVDOMICS into practice
Moderator: Lei Xiao, , M.D., Ph.D.
8:00 a.m. – 5:00 p.m. ET
Session VA.RFO.20
Thrombosis, antithrombotics, and antiplatelets
Moderator: Yogendra Kanthi, M.D.
8:00 a.m. – 5:00 p.m. ET
Session CA.ME.486 - Organ on Demand: 3D Printing for CVD
In situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid
Brenda Ogle, Ph.D.
5:00 – 5:15 p.m. ET
Session MP.AOS.450
V17 - Plasma Proteomic Profiling of Endurance Exercise Identified Changes in Extracellular Matrix Biologly Associated with Adaptations in Maximal Oxygen Uptake
Prashant Rao, M.D.
8:00 a.m. – 5:30 p.m. ET
Poster Sessions
Session DD.APS.01: P773
Novel fumarate prodrug rescues cardiomyopathy and motor function in Friedreich's Ataxia
Elena Dedkova, Ph.D.
8:00 a.m. – 5:30 p.m. ET
Session AT.APS.02: P121
Resolution of inflammation via Rvd1/fpr2 signaling in abdominal aortic aneurysms
Amanda Filiberto, M.D.
8:00 a.m. – 5:30 p.m. ET
Session AT.APS.02: P114
Isolated liver perfusion and electron microscopy reveal defect in Vldl lipidation associated with inactivation of Tm6sf2
Helen Hobbs, M.D.
8:00 a.m. – 5:30 p.m. ET
Session AT.APS.01: P105
Plasma apolipoprotein C3 is negatively associated with high lipoprotein(a) plasma levels in healthy volunteers
Anastasiya Matveyenko, Gissette Reyes-Soffer, M.D.
11:00 a.m. – 12:00 p.m. ET
Session AT.APS.01
Total lipoprotein lipase deficiency does not impact atherosclerosis development in low density lipoprotein receptor deficient mice
Debapriya Basu, Ira Goldberg, M.D.
11:00 a.m. – 12:00 p.m. ET
Session SA.APS.02: P2881
Insulin-like growth factor binding protein 2 is a novel marker of early smooth muscle cell phenotype modulation in thoracic aortic aneurysm
Albert J. Pedroza, M.D.
11:00 a.m. – 12:00 p.m. ET
Sunday, November 14, 2021
Live Sessions
Session ReSS.AOS.03
RO15 - A randomized trial of a physiologic-directed point-of-care training and debriefing intervention for cardiac arrest
Robert Sutton, M.D.
8:24 – 8:36 a.m. ET
LATE-BREAKING Session LBS.03
Posterior left pericardiotomy reduces postoperative atrial fibrillation after cardiac surgery
Mario Gaudino, M.D.
8:28 – 8:38 a.m. ET
Session AT.ME.238
Paradigm shift of understanding human atherosclerosis: Single-cell immune landscape
Chiara Giannarelli, M.D., Ph.D.
5:00 – 5:10 p.m. ET
Poster Sessions
Session AT.APS.03: P130
Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
Rupak Mukherjee Ph.D., Jeffrey Jones, Ph.D., Jean Ruddy, M.D.
11:00 a.m. – 12:00 p.m. ET
Session AT.APS.03: P130
Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
Zdravka Daneva, Ph.D.
11:00 a.m. – 12:00 p.m. ET
Session CA.APS.05
New horizons in cardioprotection
Elizabeth Murphy, Ph.D.
11:00 a.m. – 12:00 p.m. ET
Session CH.APS.07: P599
Establishing normal pediatric aortic valve cusp effective height utilizing the Pediatric Heart Network normal echo Z score project echocardiograms
Ben Goot, M.D.
11:00 a.m. – 12:00 p.m. ET
Session EP.APS.11: P1162
Are CAC scores less valuable for patients of low socioeconomic status? A Dallas Heart Study analysis
Tiffany Powell-Wiley, M.D.
11:00 a.m. – 12:00 p.m. ET
Session SA.APS.05: P2905
Health status outcomes of percutaneous coronary intervention and coronary artery bypass grating in stable coronary disease: secondary analysis of the ISCHEMIA Trial
Chetan Huded, M.D.
3:30 – 4:30 p.m. ET
Session GE.APS.04: P1320
Identification of allele-specific gene expression in association with blood pressure
Amena Keshawarz, Ph.D.
3:30 – 4:30 p.m. ET
Monday, November 15, 2021
Live Sessions
Session CE.EC.405
Customizing your career: an open discussion with distinguished panelists
Moderator: Renee Wong, Ph.D.
11:00 a.m. – 12:00 p.m. ET
LATE-BREAKING Session LBS.07
P2y12 inhibitors in noncritically ill hospitalized patients with COVID-19
Judith Hochman, M.D., Jeff Berger, M.D.
11:11 – 11:19 a.m. ET
Poster Sessions
Session QCOR.APS.04: P2664
Association of medical non-adherence to health status outcomes in the ISCHEMIA Trial
Raul Garcia, Ph.D.
8:00 a.m. – 5:00 p.m. ET
Session AC.APS.05: P51
Heterogeneity of benefit on quality of life with an invasive versus conservative strategy for chronic coronary disease. Results from the ISCHEMIA Trial
Suzanne Arnold
11:00 a.m. – 12:00 p.m. ET
Session CH.APS.12: P650
Global longitudinal strain and longitudinal early diastolic strain rate may identify those Williams syndrome patients at risk of cardiomyopathy development
Marie Carillo, M.D.
1:30 – 2:30 p.m. ET